VIKING GLOBAL INVESTORS LP 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 5:01 pm Sale |
2021-12-31 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-19,283,744 (Position Closed) |
Filing |
| 2021-02-12 8:00 pm Unchanged |
2020-12-31 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
0 (Unchanged) |
Filing |
| 2020-12-23 8:37 pm Unchanged |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
0 (Unchanged) |
Filing |
| 2020-12-21 5:28 pm Purchase |
2020-12-14 | 13G | AbCellera Biologics Inc. ABCL |
VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% |
19,283,744 (New Position) |
Filing |